Longevity Health Holdings, Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
XAGE$0.23-13.1%Stored close · as of Jul 8, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Gross sales | $444,967 | $535,978 | $869,357 | $1,070,921 |
| Discounts and allowances | (48,976) | (32,366) | (81,602) | (56,956) |
| Net sales | 395,991 | 503,612 | 787,755 | 1,013,965 |
| Cost of sales | 160,455 | 200,954 | 315,194 | 441,484 |
| Gross profit | 235,536 | 302,658 | 472,561 | 572,481 |
| | | | | |
| Operating expenses: | | | | |
| Selling and marketing | 191,438 | 345,505 | 462,075 | 626,054 |
| Research and development | 73,351 | 228,606 | 128,839 | 425,518 |
| General and administrative | 681,559 | 1,564,967 | 1,905,913 | 2,840,128 |
| Depreciation and amortization of intangible assets | 13,338 | 22,184 | 28,376 | 46,136 |
| Total operating expenses | 959,686 | 2,161,262 | 2,525,203 | 3,937,836 |
| | | | | |
| Loss from operations | (724,150) | (1,858,604) | (2,052,642) | (3,365,355) |
| | | | | |
| Other income (expense): | | | | |
| Other income | 89 | 4,357 | 949 | 10,234 |
| Interest expense | (2,153) | (2,561) | (5,603) | (7,554) |
| Change in fair value of earnout liabilities | 55,996 | (29,630) | 152,049 | (29,630) |
| Inventory write-down | (38,917) | — | (235,601) | — |
| Loss on litigation settlement | (1,174,155) | — | (1,174,155) | — |
| Total other income (expense) | (1,159,140) | (27,834) | (1,262,361) | (26,950) |
| | | | | |
| Loss from operations before income taxes | (1,883,290) | (1,886,438) | (3,315,003) | (3,392,305) |
| | | | | |
| Income tax expense | — | — | — | — |
| | | | | |
| Net loss | $(1,883,290) | $(1,886,438) | $(3,315,003) | $(3,392,305) |
| | | | | |
| Net loss per common share - basic and diluted: | $(0.76) | $(1.56) | $(1.51) | $(3.08) |
| | | | | |
| Weighted average of common shares outstanding - basic and diluted | 2,475,321 | 1,209,809 | 2,189,205 | 1,101,174 |
-4-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.